🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability and glucose-lowering effica...
Status
Completed
Location
Multiple Locations
Start Date
2006-08-11
Trial ID
NCT02004886
This research will help us to learn if the medicine called metformin reduce...
Status
Recruiting
Location
Phoenix VA Health Care System, Phoenix, AZ
Start Date
2023-04-03
Trial ID
NCT02915198
Treatments Being Tested
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The purpose of this study is to determine the efficacy, safety and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00653185
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
This is a multicenter randomized, double-blind, placebo- and active-control...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07-27
Trial ID
NCT02492763
Treatments Being Tested
This is a 24 week study comparing the efficacy of four dose levels of INT13...
Status
Completed
Location
Northern California Research
Start Date
2008-02
Trial ID
NCT00631007
Treatments Being Tested
The purpose of this study is to determine the effects of metformin on funct...
Status
Terminated
Location
Baker IDI Heart and Diabetes Institute
Start Date
2013-07
Trial ID
NCT01799057
This is a phase 1, randomized, double-blind, placebo-controlled, 2-center, ...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02430870